Literature DB >> 16842963

Pathologic, radiologic and PET scan response of gastrointestinal stromal tumors after neoadjuvant treatment with imatinib mesylate.

B K P Goh1, P K H Chow, K L Chuah, W M Yap, W K Wong.   

Abstract

AIM: The aim of this study is to review the radiologic, PET scan and pathologic response and the outcome of patients with advanced GIST treated with neoadjuvant IM followed by surgical resection.
MATERIALS AND METHODS: We report a case and review 36 patients reported in MEDLINE with advanced GIST treated with neoadjuvant IM followed by surgical resection.
RESULTS: Thirty-seven patients with a median age of 56 years (range, 32-76 years) at presentation were treated with neoadjuvant IM. Radiologic response accurately predicted pathological response in 31/36 patients, whereas PET scan was accurate in predicting treatment response in only 6/23 patients.
CONCLUSION: This study demonstrates that the pathologic response of GIST to IM is usually incomplete and does not correlate with the complete response seen on PET scan. This finding suggests that surgical resection will continue to play a vital role in the treatment of patients with advanced disease responding to IM treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16842963     DOI: 10.1016/j.ejso.2006.06.004

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

1.  Pathologic complete response with neoadjuvant imatinib for locally advanced pelvic GIST.

Authors:  Carla Rameri Alexandre Silva de Azevedo; Tadeu Ferreira Paiva; Benedito Mauro Rossi; Gustavo Cardoso Guimarães; Maria Dirlei Ferreira de Souza Begnami; Thiago Bueno Oliveira; Milton José Barros E Silva; Marcello Ferretti Fanelli; Celso Abdon Lopes de Mello
Journal:  Int J Clin Oncol       Date:  2010-10-05       Impact factor: 3.402

2.  PET and PET/CT in gastrointestinal stromal tumours: the unanswered questions and the potential newer applications.

Authors:  Sandip Basu
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-18       Impact factor: 9.236

Review 3.  [Aspects of surgical treatment for gastro-intestinal stromal tumors].

Authors:  P Hohenberger
Journal:  Radiologe       Date:  2009-12       Impact factor: 0.635

4.  Feasibility and oncological outcomes of limited duodenal resection in patients with primary nonmetastatic duodenal GIST.

Authors:  Ahmed El-Gendi; Saba El-Gendi; Mohamed El-Gendi
Journal:  J Gastrointest Surg       Date:  2012-09-25       Impact factor: 3.452

5.  Outcome after curative resection of large (>or=10 cm) gastric gastrointestinal stromal tumors: how frequent is adjacent organ involvement and is concomitant distal pancreatectomy necessary?

Authors:  Brian K P Goh; Pierce K H Chow; Sittampalam M Kesavan; Wai-Ming Yap; Yaw-Fui A Chung; Wai-Keong Wong
Journal:  J Gastrointest Surg       Date:  2010-04       Impact factor: 3.452

6.  Limited resection for duodenal gastrointestinal stromal tumors: Surgical management and clinical outcome.

Authors:  Jens Hoeppner; Birte Kulemann; Goran Marjanovic; Peter Bronsert; Ulrich Theodor Hopt
Journal:  World J Gastrointest Surg       Date:  2013-02-27

7.  Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor.

Authors:  Chaoyong Shen; Haining Chen; Yuan Yin; Jiaju Chen; Bo Zhang; Zhixin Chen; Jiaping Chen
Journal:  Clinics (Sao Paulo)       Date:  2014-11       Impact factor: 2.365

8.  Surgical treatment of gastric gastrointestinal stromal tumor.

Authors:  Seong-Ho Kong; Han-Kwang Yang
Journal:  J Gastric Cancer       Date:  2013-03-31       Impact factor: 3.720

9.  Management of gastrointestinal stromal tumours in the Imatinib era: a surgeon's perspective.

Authors:  Ravindra S Date; Nicholas A Stylianides; Kishore G Pursnani; Jeremy B Ward; Muntzer M Mughal
Journal:  World J Surg Oncol       Date:  2008-07-18       Impact factor: 2.754

10.  Using endoscopy to minimize the extent of resection in the management of giant GISTs of the stomach.

Authors:  Hishaam Ismael; Yury Ragoza; Steven Cox
Journal:  Int J Surg Case Rep       Date:  2017-04-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.